Skip to main content
SpringerLink
Log in

Type II diabetes and dementia

  • Letter to the Editor
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

The Original Article was published on 22 August 2019

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kawada T (2019) Type II diabetes treatment and risk of dementia. Acta Diabetologica. https://doi.org/10.1007/s00592-019-01399-2

    Article  PubMed  Google Scholar 

  2. Buchmann N et al (2019) Different treatment forms of type II diabetes and the risk of dementia in German health claims data. Acta Diabetologica 56(9):995–1003. https://doi.org/10.1007/s00592-019-01332-7

    Article  PubMed  Google Scholar 

  3. Hughes TM, Craft S (2016) The role of insulin in the vascular contributions to age-related dementia. Biochim Biophys Acta 1862(5):983–991

    Article  CAS  Google Scholar 

  4. Cao B et al (2018) Comparative efficacy and acceptability of antidiabetic agents for Alzheimer’s disease and mild cognitive impairment: a systematic review and network meta-analysis. Diabetes Obes Metab 20(10):2467–2471

    Article  Google Scholar 

  5. McIntosh EC, Nation DA (2019) Importance of treatment status in links between type 2 diabetes and Alzheimer’s disease. Diabetes Care 42(5):972–979

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to the Scientific Research Institute of the AOK, WIdO, for providing the data.

Author information

Authors and Affiliations

  1. Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Lipid Clinic at the Interdisciplinary Metabolism Center, Humboldt-Universität zu Berlin, Berlin, Germany

    Nikolaus Buchmann, Christina Tegeler, Ilja Demuth & Elisabeth Steinhagen-Thiessen

  2. Charité - Universitätsmedizin Berlin, BCRT - Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany

    Nikolaus Buchmann, Christina Tegeler, Ilja Demuth & Elisabeth Steinhagen-Thiessen

  3. German Center for Neurodegenerative Diseases, Sigmund-Freud-Str. 25, 53127, Bonn, Germany

    Anne Fink & Gabriele Doblhammer

  4. Rostock Center for the Study of Demographic Change, Konrad-Zuse-Str. 1, 18057, Rostock, Germany

    Anne Fink & Gabriele Doblhammer

  5. Institute for Sociology and Demography, University Rostock, Ulmenstr. 69, 18057, Rostock, Germany

    Gabriele Doblhammer

  6. Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany

    Nikolaus Buchmann

Authors
  1. Nikolaus Buchmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christina Tegeler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ilja Demuth
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gabriele Doblhammer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elisabeth Steinhagen-Thiessen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gabriele Doblhammer.

Ethics declarations

Conflict of interest

Dr. Steinhagen-Thiessen reports grants and personal fees from Sanofi, personal fees from MSD, Fresenius, personal fees from Amgen and Chiesi, outside the submitted work. Dr. Demuth reports grants from Sanofi, personal fees from uniQure biopharma B.V., outside the submitted work. Prof. Doblhammer-Reiter received honoraries from Eli Lilly and Novartis not related to the study.

Ethical standard

This article does not contain any studies with human or animal subjects performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

Additional information

Managed by Massimo Porta.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buchmann, N., Fink, A., Tegeler, C. et al. Type II diabetes and dementia. Acta Diabetol 57, 249–250 (2020). https://doi.org/10.1007/s00592-019-01400-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-019-01400-y

Search

Navigation